Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Willis Towers Watson, Holding 7.6% of Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.6% passive ownership stake in Willis Towers Watson PLC as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, reporting a 9.0% beneficial ownership stake in nVent Electric plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Allegion Public Limited Company, Discloses 7.5% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.5% beneficial ownership stake in Allegion Public Limited Company as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.7% Passive Stake in Trane Technologies plc
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.7% beneficial ownership stake in Trane Technologies plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.5% Stake in National Grid PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.5% of National Grid PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.3% beneficial ownership stake in consumer health company Haleon PLC as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing its beneficial ownership of 11.1% of Luxfer Holdings PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% beneficial ownership stake in Shell plc's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.0% beneficial ownership stake in Diversified Energy Co PLC as of March 31, 2025, held for investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Kiniksa Pharmaceuticals, Reports 5.4% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 5.4% beneficial ownership stake in Kiniksa Pharmaceuticals International, plc as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.2% Stake in AngloGold Ashanti PLC
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in AngloGold Ashanti PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.5% Stake in British American Tobacco PLC
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% of British American Tobacco PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 8.2% of Pearson PLC's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.8% passive beneficial ownership stake in Prudential Public Limited Company as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a 5.3% beneficial ownership stake in Lions Gate Entertainment Corp's Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.3% Stake in Wheaton Precious Metals Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.3% beneficial ownership stake in Wheaton Precious Metals Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, disclosing a 5.8% passive beneficial ownership stake in Logitech International S.A. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.4% Passive Stake in Transocean Ltd.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 6.4% of Transocean Ltd.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.9% Passive Stake in Alcon Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.9% beneficial ownership stake in Alcon Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.6% Stake in Genmab A/S Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.6% beneficial ownership stake in Genmab A/S as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.2% Passive Stake in Novo Nordisk A/S
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.2% beneficial ownership stake in Novo Nordisk A/S as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Sanofi Stake, Discloses 5.8% Passive Ownership
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 5.8% passive beneficial ownership stake in Sanofi's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends RELX PLC Stake Disclosure, Maintains Significant Beneficial Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing a beneficial ownership of 8.5% in RELX PLC as of March 31, 2025, holding 156,506,450 common shares.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.6% beneficial ownership stake in Unilever PLC as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.6% Passive Stake in BHP Group Ltd
BlackRock, Inc. has filed an updated Schedule 13G, revealing a 5.6% beneficial ownership stake in BHP Group Ltd as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 14 to Schedule 13G, disclosing its beneficial ownership of 8.1% of Invesco Ltd.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 14 to its Schedule 13G, reporting a 7.6% beneficial ownership stake in Everest Group Ltd as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in James River Group Holdings to 6.3%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.3% beneficial ownership stake in James River Group Holdings, Ltd. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends SiriusPoint Ltd. Stake Disclosure, Reports 8.9% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, disclosing a beneficial ownership of 8.9% in SiriusPoint Ltd.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.6% Passive Stake in SunOpta Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.6% passive beneficial ownership stake in SunOpta Inc.'s common stock as of March 31, 2025.